Driving CAR T cell translation forward-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Driving CAR T cell translation forward

Published:2019-02-27 Issue:481 Volume:11 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Schultz Liora¹,Mackall Crystal¹²³^ORCID

Affiliation:

1. Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA.

2. Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.

3. Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.

Abstract

Successes in CAR T cell translation have propelled their commercial launch, but expanding the impact of cancer immunotherapies remains challenging.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference10 articles.

1. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia

2. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

3. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

4. Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 + and CD4 + CD19-specific chimeric antigen receptor–modified T cells

5. Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel CAR‐T Cells Specifically Targeting SIA‐CIgG Demonstrate Effective Antitumor Efficacy in Bladder Cancer;Advanced Science;2024-08-23

2. Expression of VISTA regulated via IFN-γ governs endogenous T-cell function and exhibits correlation with the efficacy of CD19 CAR-T cell treated B-malignant mice;Journal for ImmunoTherapy of Cancer;2024-06

3. Unlocking the Potential of Induced Pluripotent Stem Cells in Revolutionizing Cancer Therapy;Current Stem Cell Research & Therapy;2024-04-15

4. Clinical Pharmacology Considerations for the “Off‐the‐Shelf” Allogeneic Cell Therapies;Clinical Pharmacology & Therapeutics;2024-03-19

5. Immunometabolic Maladaptations to the Tumor Microenvironment;Cold Spring Harbor Perspectives in Medicine;2024-03-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3